TY - JOUR
T1 - Eicosanoid content in fetal calf serum accounts for reproducibility challenges in cell culture
AU - Niederstaetter, Laura
AU - Neuditschko, Benjamin
AU - Brunmair, Julia
AU - Janker, Lukas
AU - Bileck, Andrea
AU - Favero, Giorgia Del
AU - Gerner, Christopher
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/1/15
Y1 - 2021/1/15
N2 - Reproducibility issues regarding in vitro cell culture experiments are related to genetic fluctuations and batch‐wise variations of biological materials such as fetal calf serum (FCS). Genome sequencing may control the former, while the latter may remain unrecognized. Using a U937 mac-rophage model for cell differentiation and inflammation, we investigated whether the formation of effector molecules was dependent on the FCS batch used for cultivation. High resolution mass spec-trometry (HRMS) was used to identify FCS constituents and to explore their effects on cultured cells evaluating secreted cytokines, eicosanoids, and other inflammatory mediators. Remarkably, the FCS eicosanoid composition showed more batch‐dependent variations than the protein composi-tion. Efficient uptake of fatty acids from the medium by U937 macrophages and inflammation‐in-duced release thereof was evidenced using C13‐labelled arachidonic acid, highlighting rapid lipid metabolism. For functional testing, FCS batch‐dependent nanomolar concentration differences of two selected eicosanoids, 5‐HETE and 15‐HETE, were balanced out by spiking. Culturing U937 cells at these defined conditions indeed resulted in significant proteome alterations indicating HETE-induced PPARγ activation, independently corroborated by HETE‐induced formation of peroxi-somes observed by high‐resolution microscopy. In conclusion, the present data demonstrate that FCS‐contained eicosanoids, subject to substantial batch‐wise variation, may modulate cellular ef-fector functions in cell culture experiments.
AB - Reproducibility issues regarding in vitro cell culture experiments are related to genetic fluctuations and batch‐wise variations of biological materials such as fetal calf serum (FCS). Genome sequencing may control the former, while the latter may remain unrecognized. Using a U937 mac-rophage model for cell differentiation and inflammation, we investigated whether the formation of effector molecules was dependent on the FCS batch used for cultivation. High resolution mass spec-trometry (HRMS) was used to identify FCS constituents and to explore their effects on cultured cells evaluating secreted cytokines, eicosanoids, and other inflammatory mediators. Remarkably, the FCS eicosanoid composition showed more batch‐dependent variations than the protein composi-tion. Efficient uptake of fatty acids from the medium by U937 macrophages and inflammation‐in-duced release thereof was evidenced using C13‐labelled arachidonic acid, highlighting rapid lipid metabolism. For functional testing, FCS batch‐dependent nanomolar concentration differences of two selected eicosanoids, 5‐HETE and 15‐HETE, were balanced out by spiking. Culturing U937 cells at these defined conditions indeed resulted in significant proteome alterations indicating HETE-induced PPARγ activation, independently corroborated by HETE‐induced formation of peroxi-somes observed by high‐resolution microscopy. In conclusion, the present data demonstrate that FCS‐contained eicosanoids, subject to substantial batch‐wise variation, may modulate cellular ef-fector functions in cell culture experiments.
KW - Batch variations
KW - Eicosanoids
KW - Fetal calf serum
KW - Mass spectrometry
KW - Peroxisomes
KW - Proteomics
KW - Reproducibility of Results
KW - Humans
KW - Macrophages/metabolism
KW - Eicosanoids/metabolism
KW - Hydroxyeicosatetraenoic Acids
KW - U937 Cells
KW - Peroxisomes/metabolism
KW - Fatty Acids/analysis
KW - Serum Albumin, Bovine/chemistry
KW - Cell Culture Techniques
UR - http://www.scopus.com/inward/record.url?scp=85100121398&partnerID=8YFLogxK
U2 - 10.3390/biom11010113
DO - 10.3390/biom11010113
M3 - Article
C2 - 33467719
AN - SCOPUS:85100121398
SN - 2218-273X
VL - 11
SP - 1
EP - 13
JO - Biomolecules
JF - Biomolecules
IS - 1
M1 - 113
ER -